Publications

Frankenfeld CL, Movva N, Hooda N, Gauthier J, Reichert H, Doepker C. 2026. Analysis of National Health and Nutrition Survey (NHANES): Nutrient, food, and beverage intake of GLP-1-RA users with type 2 diabetes, 2007-2020. J Nutr 101685; doi: 10.1016/j.tjnut.2026.101685. Online ahead of print June 22. PMID: 42331063.

Buerger AN, Thompson CM, Heintz MM, Maberti S, Palermo CM, Haws LC. 2026. Application of quantitative and qualitative uncertainty assessment risk management decision-making: A case study with diisononyl phthalate. Food Chem Toxicol 214(Aug):116110; doi: 10.1016/j.fct.2026116110. PMID: 42035978.

Fender CL, Morshead M, Schindler J, Williamson M, Brown K, Cohen C, Feldman L, et al. 2026. Addressing community concerns about unregulated organic contaminants in surface water: Integrating suspect and non-targeted chemical analyses with Zebrafish toxicity testing and computational hazard comparisons. Environ Pollut 399(15 June):128103; doi: 10.1016/j.envpol.2026.128103. PMID: 41997357.

Kirman CR, Lipscomb JC, Rogers J, Schoeny RS, Seed JG, Sonawane BR, Hays SM. 2026. Evaluation of the modes of action for key noncancer effects of 1,3-Butadiene: Input from an independent expert panel to support derivation of data-derived extrapolation factors. Crit Rev Toxicol; doi: 10.1080/10408444.2026.2661191. Online ahead of print June 9. PMID: 42261678.

Bond G, Becker RA, Rish W, Ryman JP, Verwiel AH. 2026. Cumulative impact assessment within vulnerable communities: Challenges, opportunities and path forward. J Toxicol Regul Pol 2(1):1-19; doi: 10.69982/JTRP-25-0012.

Flume PA, Nordyke RJ, Han D, Jha A, Nicholson G, Peipert JD. 2026. Patient-reported outcome measures developed for non-cystic fibrosis bronchiectasis may be applied to cystic fibrosis bronchiectasis. Health Qual Life Outcomes; doi: 10.1186/s12955-026-02546-4. Online ahead of print May 13. PMID: 42129785.

Thompson CM, Heintz MM, Rogers SI, Vincent MJ, Haws LC. 2026. Integration of mechanistic and repeat dose toxicity data in the derivation of an oral reference dose for HFPO-DA. Toxicol Sci 209(5):kfag045; doi: 10.1093/toxsci/kfag045. PMID: 41968070.

Buerger AN, Heintz MM, Haws LC, Thompson CM. 2026. Mode-of-action and human relevance assessment for diisononyl phthalate-induced liver tumors in rodents. J Appl Toxicol; doi: 10.1002/jat.70223. Online ahead of print May 5th. PMID: 42086044. 

Pimenta K, Edwards J, Ray M, Naser AM, Price C, Idassi O, Strong K, Were W, et al. 2026. Contemporary global burden of sickle cell anaemia under-5 and under-20: A systematic review and meta-analysis. Br J Haematol 10.1111/bjh.70501. Online ahead of print May 3; doi: 10.1111/bjh.70501. PMID: 42070793.

Doepker C, Franzen A, Brorby G, Brown L, Choksi N, East A, Wikoff D. 2026. Smoke flavoring—A case study demonstrating the value of using benefit-risk analysis for foods (BRAFO) to provide transparency for risk management decisions. Regul Toxicol Pharmacol 167(May):106033; doi: 10.1016/j.yrtph.2026.106033. PMID: 41577161.

Lea IA, Buerger AN, Vincent MJ,…, Choksi NY, Schaefer H, Britt J, Fitch S, Haws L, Borghoff SJ. 2026. Evaluating the potential carcinogenic hazard of diisononyl phthalate in humans via systematic integration of human, animal cancer studies, and mechanistic data. Curr Res Toxicol 10(Apr 30):100295; doi: 10.1016/j.crtox.2026.100295.

Mahony C, Bartlett A, Fitzpatrick S, Galli C, Hunt P, Inselman A, Jimenez J,…, Rogers J, et al. 2026. A screening strategy for identifying the developmental and reproductive toxicity potential of botanicals. 64(1):639-557; doi: 10.1080/13880209.2026.2659421. PMID: 42048162.

Buerger AN, Vincent MJ, Fitch S, Rivera B, Engel N, Zhang J, Rushton EK, Borghoff SJ. 2026. A mechanistic evaluation of the metabolism disrupting potential of methyl tert-butyl ether. Curr Res Toxicol 10(Apr 20):100290; doi: 10.1016/j.crtox.2026.100290. PMID: 42057916.

Massarsky A, Evans VJB, Fung ES, Yang LGL, Rogers KL, Buerger AN, Maier A, Reichard JF. A framework for assessing the safety of degraded pharmaceuticals for long-duration space missions—Part II: Framework application in four case studies. Crit Rev Toxicol; doi: 10.1080/10408444.2026.2633422. Online ahead of print April 16. PMID: 41988975.

Summan M, Doepker CL, Brorby GP. 2026. Safety evaluation of an aqueous root and leaf extract of Ashwagandha (Withania somnifera). Phytother Res; doi: 10.1002/ptr.70314. Online ahead of print April 15. PMID: 41987003.

Massarsky A, Evans VJB, Fung ES, Yang LGL, Rogers KL, Buerger AN, Maier A, Reichard JF. A framework for assessing the safety of degraded pharmaceuticals that will be required for long-duration space missions—Part I: Framework development. Crit Rev Toxicol; doi: 10.1080/10408444.2025.2533943. Online ahead of print April 9. PMID: 4195218.

Killius A, Wheeler M, Covell L, Price S, Finley B. 2026. Derivation of provisional chronic oral toxicity values (PCOTV) for novel short-chain PFAS congeners. J Appl Toxicol; doi: 10.1002/jat.70156. Online ahead of print March 12. PMID: 41814952.

Greenfield MR, Frankenfeld C, Pendala A, Ozmeral A, Pendala V, Baustian N, Seng EK, Pavlovic JM, et al. 2026. Variations of dietary intake across migraine phases in adults with episodic migraine: A prospective observational pilot study. Curr Dev Nutr 10(4):107668; doi: 10.1016/j.cdnut.2026.107668. PMID: 41970508.

Faske JB, Gong B, LeBlanc DP, Funk J, Zhou G, Kehm S, White PA, Robison T, et al. 2026. Expansion of preexisting cancer driver mutant clones is induced by the genotoxic carcinogen benzo[b]fluoranthene in MutaMouse lung. Toxicol Sci 209(3):kfag030; doi: 10.1093/toxsci/kfag030. PMID: 41859812.